Department of Radiology, İstanbul Training and Research Hospital, İstanbul, Turkey.
Department of Radiology, Basaksehir Cam and Sakura City Hospital, İstanbul, Turkey.
BMC Med Imaging. 2023 Oct 18;23(1):160. doi: 10.1186/s12880-023-01113-3.
CT-guided radiofrequency ablation (RFA) is among the thermal ablative procedures and provides great benefits with a minimally invasive procedure. In this prospective study, we aimed to reveal the significance of a multidisciplinary method in reducing the recurrence and complications in osteoid osteoma patients with CT-guided RFA performed by a team of experts in the field.
A total of consecutive 40 patients with osteoid osteoma were prospectively evaluated and treated with CT-guided RFA. Before and the post ablation the visual analog scale (VAS) and use of nonsteroidal anti-inflammatory drugs (NSAIDS) were compared.
Post-ablation VAS of the patients at the 1st week and 3rd month after the procedure decreased significantly (p < 0.01) compared to the pre-ablation. The frequency of NSAID use after the ablation decreased significantly (p < 0.01) compared to the pre-ablation time. The pre-procedure NSAID use of our patients included in the study was average 6.93 per week, the NSAID use in the 3rd month post-procedure controls was average 0.53 per week. Recurrence was detected in 4 of our patients, 36 patients had complete recovery.
Radiofrequency ablation is an effective treatment method in the management of osteoid osteomas. Radiofrequency ablation has low recurrence rates and provides rapid regression in patients' pain after treatment.
CT 引导下射频消融（RFA）是热消融程序之一，通过由该领域专家组成的团队进行微创操作，具有显著优势。在这项前瞻性研究中，我们旨在揭示多学科方法在降低骨样骨瘤患者 CT 引导下 RFA 后复发和并发症方面的重要性。
共连续评估和治疗了 40 例骨样骨瘤患者，采用 CT 引导下 RFA。比较消融前后的视觉模拟评分（VAS）和非甾体抗炎药（NSAIDs）的使用情况。
与消融前相比，术后第 1 周和第 3 个月的患者 VAS 明显降低（p<0.01）。与消融前相比，消融后 NSAID 的使用频率明显降低（p<0.01）。研究中纳入的患者在术前 NSAID 的平均使用频率为每周 6.93 次，术后第 3 个月的 NSAID 使用频率平均为每周 0.53 次。我们的 4 名患者中有 4 名出现复发，36 名患者完全康复。
射频消融是骨样骨瘤治疗的有效方法。射频消融后患者疼痛迅速缓解，复发率低。
